JOINT FILING AGREEMENT
EXHIBIT 99.1
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Eledon Pharmaceuticals, Inc.
Date: February 14, 2025
▇▇▇▇▇▇▇ LIFE SCIENCES PUBLIC FUND, L.P.
By: FHMLSP, L.P., its General Partner
By: FHMLSP, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLSP, L.P.
By: FHMLSP, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLSP, L.L.C.
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
▇▇▇▇▇▇▇ LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.
By: FHMLSP Overage, L.P., its General Partner
By: FHMLSP Overage, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLSP OVERAGE, L.P.
By FHMLSP Overage, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLSP OVERAGE, L.L.C.
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
▇▇▇▇▇▇▇ LIFE SCIENCES XI, L.P.
By: FHMLS XI, L.P., its General Partner
By: FHMLS XI, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLS XI, L.P.
By: FHMLS XI, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLS XI, L.L.C.
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
▇▇▇▇▇▇▇ LIFE SCIENCES X, L.P.
By: FHMLS X, L.P., its General Partner
By: FHMLS X, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLS X, L.P.
By: FHMLS X, L.L.C., its General Partner
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
FHMLS X, L.L.C.
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Financial Officer
Date: February 14, 2025
By: *
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Date: February 14, 2025
By: *
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Date: February 14, 2025
By: **
▇▇▇▇▇▇ ▇▇▇
Date: February 14, 2025
By: **
▇▇▇▇▇ ▇▇▇▇▇
Date: February 14, 2025
By: ***
▇▇▇▇▇▇ ▇▇▇▇▇
Date: February 14, 2025
By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇, as Attorney-in-Fact
*This Joint Filing Agreement was executed by ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016.
**This Joint Filing Agreement was executed by ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.
***This Joint Filing Agreement was executed by ▇▇▇▇▇ ▇. ▇▇▇▇▇▇ on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022.